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Background
Milk allergy is the most common food allergy in infants
and young children. Typical milk allergy symptoms involve
hives, vomiting, or even anaphylaxis. For cow’s milk, strict
avoidance is difficult because milk proteins are very ubiqui-
tous. Oral immunotherapy (OIT) is an effective therapeutic
option to induce milk oral tolerance. However, the
immune mechanisms underlying this treatment have not
been fully identified yet. The aim of this study was to com-
pare the clinical and immune responses against several
milk allergens of a pediatric population before an OIT pro-
tocol with a non-atopic population of the same age range.
Methods
A group of 9 patients with IgE-mediated milk allergy, con-
firmed by positive double blind placebo controlled test
(DBPCT), was compared with a group of 8 non-atopic peo-
ple on a milk-containing diet. The mean age of milk-aller-
gic patients was 4.7 years compared with 6.0 years in the
control group. No significant differences regarding sex or
age were found between them. In both groups, PBMCs
were isolated from peripheral blood and stimulated during
7 days with b-casein (b-Cn), a-lactalbumin (a-La) and
b-lactoglobulin (b-Lg). Culture supernatants were analyzed
for IL-5, IL-13, IL-1b, IFN-g, TNF-a and IL-10 production
by Cytometric Bead Array (CBA).
Results
During the DBPCT with milk, 6 milk-allergic patients had
urticaria, 1 referred digestive symptoms and 1 respiratory
symptoms. The mean positive dose in the DBPCT was
15.4 mL of milk, within a range of 0.3-64 mL. Specific IgE
measurements were, on average, 37.9 kU/L for milk,
40.1 kU/L for casein, 28.63 kU/L for a-La and 17.45 kU/L
for b-Lg.
CBA analysis revealed a significantly increased pro-
duction of b-Lg and b-Cn-specific IL-5 and IL-13
(P<0.05), together with a trend towards lower a-La
(P=0.09) and b-Lg (P=0.06)-stimulated TNF-a, in milk-
allergic patients as compared with control children.
Conclusion
Under the conditions studied, milk-allergic patients showed
a significantly enhanced Th2 cytokine production after sti-
mulation with milk allergens in comparison with non-atopic
controls. In addition, a trend towards lower TNF-a produc-
tion was observed. From the results obtained, it can be con-
cluded that stimulation with both b-Lg and b-Cas shifted
the T-cells phenotype to a Th2 profile, which is well corre-
lated with the clinical response observed during the
DBPCT. Studies are underway aiming to establish the role
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